W. Mark Roberts

622 total citations
16 papers, 412 citations indexed

About

W. Mark Roberts is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, W. Mark Roberts has authored 16 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 9 papers in Hematology and 3 papers in Genetics. Recurrent topics in W. Mark Roberts's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Lymphocytic Leukemia Research (3 papers). W. Mark Roberts is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Lymphocytic Leukemia Research (3 papers). W. Mark Roberts collaborates with scholars based in United States. W. Mark Roberts's co-authors include Theodore F. Zipf, KW Chan, Hazem H. Mahmoud, Raul C. Ribeiro, RA Krance, Craig A. Hurwitz, Zeev Estrov, Ray Hachem, Michael J. Keating and Maher Albitar and has published in prestigious journals such as The Lancet, Blood and Clinical Infectious Diseases.

In The Last Decade

W. Mark Roberts

15 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Mark Roberts United States 11 183 145 95 70 63 16 412
Svein Kolmannskog Norway 13 124 0.7× 198 1.4× 40 0.4× 50 0.7× 39 0.6× 28 428
D Sońta-Jakimczyk Poland 9 89 0.5× 99 0.7× 41 0.4× 70 1.0× 13 0.2× 69 291
T. C. M. Morris United Kingdom 13 152 0.8× 41 0.3× 75 0.8× 123 1.8× 57 0.9× 40 530
C. N. Nair India 13 121 0.7× 104 0.7× 33 0.3× 84 1.2× 25 0.4× 30 327
A. Sarrat France 7 183 1.0× 30 0.2× 34 0.4× 67 1.0× 58 0.9× 22 447
Laura Marbello Italy 10 105 0.6× 39 0.3× 28 0.3× 84 1.2× 143 2.3× 20 388
Pedro Renato Chocair Brazil 9 55 0.3× 264 1.8× 47 0.5× 31 0.4× 130 2.1× 32 484
J E McDermed United States 7 29 0.2× 27 0.2× 74 0.8× 60 0.9× 25 0.4× 11 514
Abderrahman Abdelkefi Tunisia 10 115 0.6× 25 0.2× 47 0.5× 37 0.5× 26 0.4× 16 331
Martin Griebel Germany 10 18 0.1× 47 0.3× 88 0.9× 56 0.8× 31 0.5× 12 476

Countries citing papers authored by W. Mark Roberts

Since Specialization
Citations

This map shows the geographic impact of W. Mark Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Mark Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Mark Roberts more than expected).

Fields of papers citing papers by W. Mark Roberts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Mark Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Mark Roberts. The network helps show where W. Mark Roberts may publish in the future.

Co-authorship network of co-authors of W. Mark Roberts

This figure shows the co-authorship network connecting the top 25 collaborators of W. Mark Roberts. A scholar is included among the top collaborators of W. Mark Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Mark Roberts. W. Mark Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Chatzinikolaou, Ioannis, Theodore F. Zipf, Hend Hanna, et al.. (2003). Minocycline‐Ethylenediaminetetraacetate Lock Solution for the Prevention of Implantable Port Infections in Children with Cancer. Clinical Infectious Diseases. 36(1). 116–119. 71 indexed citations
3.
Bunin, Nancy, Dennis A. Johnston, W. Mark Roberts, et al.. (2003). Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features. British Journal of Haematology. 120(4). 711–715. 10 indexed citations
4.
Núnêz, César, Theodore F. Zipf, W. Mark Roberts, et al.. (2003). Molecular Monitoring of Cerebrospinal Fluid Can Predict Clinical Relapse in Acute Lymphoblastic Leukemia With Eosinophilia. Archives of Pathology & Laboratory Medicine. 127(5). 601–605. 18 indexed citations
5.
Kantarjian, Hagop M., et al.. (2000). Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.. Archives of Pathology & Laboratory Medicine. 124(1). 92–7. 25 indexed citations
6.
Kantarjian, Hagop M., et al.. (2000). Terminal Deoxynucleotidyl Transferase–Negative Acute Lymphoblastic Leukemia. Archives of Pathology & Laboratory Medicine. 124(1). 92–97. 28 indexed citations
7.
Tran, Hai T., et al.. (1999). Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide. Bone Marrow Transplantation. 24(9). 947–952. 18 indexed citations
8.
Mullen, Craig A., Demetrios Petropoulos, W. Mark Roberts, et al.. (1999). Economic and Resource Utilization Analysis of Outpatient Management of Fever and Neutropenia in Low-Risk Pediatric Patients With Cancer. Journal of Pediatric Hematology/Oncology. 21(3). 212–218. 42 indexed citations
9.
Roberts, W. Mark, et al.. (1998). Bone marrow transplantation in Shwachman–Diamond syndrome: report of two cases and review of the literature. Bone Marrow Transplantation. 21(8). 849–851. 44 indexed citations
10.
Roberts, W. Mark, Zeev Estrov, Geoffrey R. Kitchingman, & Theodore F. Zipf. (1996). The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification of antigen-receptor gene sequences. Leukemia & lymphoma. 20(3-4). 181–197. 26 indexed citations
11.
Roberts, W. Mark, Zeev Estrov, Geoffrey R. Kitchingman, & Theodore F. Zipf. (1996). Detection of minimal residual disease in all: biology, methods, and applications. Cancer treatment and research. 84. 149–166. 7 indexed citations
12.
Roberts, W. Mark, Zeev Estrov, & T. F. Zipf. (1995). Detection of minimal residual disease in acute lymphoblastic leukemia [letter; comment]. Blood. 86(3). 1237–1239. 2 indexed citations
13.
Roberts, W. Mark, T. F. Zipf, Geoffrey R. Kitchingman, D G Tubergen, & Zeev Estrov. (1995). Monitoring residual disease in acute lymphoblastic leukemia: therapeutic implications.. PubMed. 1(1). 65–9. 3 indexed citations
14.
Roberts, W. Mark, Gaston K. Rivera, Susana C. Raimondi, et al.. (1994). Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. The Lancet. 343(8893). 331–332. 35 indexed citations
15.
Annett, Geralyn, et al.. (1994). Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.. PubMed. 8(11). 1871–8. 18 indexed citations
16.
Mahmoud, Hazem H., et al.. (1993). Tretinoin toxicity in children with acute promyelocytic leukaemia. The Lancet. 342(8884). 1394–1395. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026